The cardiovascular phenotype of childhood hypertension: a cardiac magnetic resonance study by Cheang, MH et al.
ORIGINAL ARTICLE
The cardiovascular phenotype of childhood hypertension: a cardiac
magnetic resonance study
Mun H. Cheang1 & Gregorz T. Kowalik1 & Michael A. Quail1 & Jennifer A. Steeden1 & Daljit Hothi2 & Kjell Tullus2 &
Vivek Muthurangu1
Received: 28 August 2018 /Revised: 7 January 2019 /Accepted: 21 February 2019 /Published online: 3 May 2019
# The Author(s) 2019
Abstract
Background The cardiovascular phenotype is poorly characterized in treated pediatric hypertension. Cardiovascular magnetic
resonance imaging (MRI) can be used to better characterize both cardiac and vascular phenotype in children with hypertension.
Objective To use MRI to determine the cardiac and vascular phenotypes of different forms of treated hypertension and compare
the results with those of healthy children.
Materials and methods Sixty children (15 with chronic renal disease with hypertension, 15 with renovascular hypertension, 15 with
essential hypertension and 15 healthy subjects) underwent MRI with noninvasive blood pressure measurements. Cardiovascular
parametersmeasured include systemic vascular resistance, total arterial compliance, left ventricular mass and volumetric data, ejection
fraction and myocardial velocity. Between-group comparisons were used to investigate differences in the hypertension types.
Results Renal hypertension was associated with elevated vascular resistance (P≤0.007) and normal arterial compliance. Conversely,
children with essential hypertension had normal resistance but increased compliance (P=0.001). Renovascular hypertension was
associated with both increased resistance and compliance (P≤0.03). There was no difference in ventricular volumes, mass or cardiac
output between groups. Children with renal hypertension also had lower systolic and diastolic myocardial velocities.
Conclusion Cardiovascular MRI may identify distinct vascular and cardiac phenotypes in different forms of treated childhood
hypertension. Future studies are needed to investigate how this may inform further optimisation of blood pressure treatment in
different types of hypertension.
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Introduction
Pediatric hypertension is a rare but serious condition, with a
prevalence of approximately 3–6% [1, 2]. Chronic kidney
disease, renal artery stenosis and essential hypertension are
the most common causes of hypertension in children [3, 4].
Although elevated blood pressure is a common feature, it is
unclear which components of vascular function (resistance,
compliance or cardiac output) are abnormal in each condition.
This is because comprehensive vascular phenotyping is diffi-
cult to perform using conventional noninvasive techniques.
Recently, cardiovascular magnetic resonance imaging (MRI)
has been combined with noninvasive pressure measurements
to accurately evaluate vascular function in children. Using this
technique, it has been shown that children with renal disease
have raised systemic vascular resistance compared to healthy
children [5]. We believe this approach could be used to ex-
plore different vascular phenotypes in pediatric hypertension.
Another benefit of MRI is that it enables simultaneous
cardiac phenotyping. This includes reference standard assess-
ment of left ventricular mass and volumes [6], as well as novel
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evaluation of cardiac timings, mitral inflow and myocardial
velocities [7, 8]. This ability is useful as the myocardial re-
sponse to hypertension may also vary depending on the un-
derlying cause.
The aim of this study is to use to MRI to determine the
cardiac and vascular phenotypes of children with renal disease
and hypertension, renovascular disease and essential hyper-
tension and to compare the results with those of healthy
children.
Materials and methods
Study population
The study population consisted of 60 children: 15 children
with renal parenchymal disease and hypertension (renal),
15 children with renal artery stenosis associated hyperten-
sion (renovascular), 15 children with idiopathic essential
hypertension and 15 healthy controls. Only patients with
stable, treated hypertension were recruited. Exclusion
criteria were: 1) age <7 or >18 years, 2) congenital struc-
tural heart disease or primary myocardial disease, 3) sig-
nificant renal impairment in renovascular or essential hy-
pertension, 4) active vasculitis, 5) cardiac arrhythmia pre-
cluding the use of cardiac gated MRI sequences, 6) medi-
cal devices precluding MRI, 7) other causes of secondary
hypertension, and 8) current or previous renal replacement
therapy. The exclusion criteria were selected to ensure that
the study groups did not have any other condition that may
account for cardiovascular abnormalities.
This study was approved by the United Kingdom national
research ethics service (National Research Ethics Service
Committee London, London Bridge, REC reference: 15/LO/
0213). Informed parental consent and patient assent were ob-
tained from all participants. Patients were consecutively re-
cruited from hypertension and renal clinics in Great Ormond
Street Hospital over 24 months.
The renal group was a subset of a previously examined
group of pediatric chronic kidney disease patients who had
been phenotyped using MRI [5]. Only renal patients with a
confirmed diagnosis of hypertension were included in this
study.
In the renovascular group, renal artery stenosis was con-
firmed with a combination of noninvasive and invasive inves-
tigations [9]. All renovascular children received the optimal
treatment plan as recommended following discussion by a
multidisciplinary clinical team.
The essential hypertension group was clinically eval-
uated to exclude other secondary causes of hypertension
and treated according to published recommendations
[10].
Imaging protocol
Imaging was performed on a 1.5-T MRI system (Avanto;
Siemens Medical Solutions, Erlangen, Germany). All MRI
data were processed using in-house plug-ins developed for
open-source DICOM (Digital Imaging and Communications
in Medicine) software OsiriX [11] (the OsiriX Foundation,
Geneva, Switzerland) by the same individual (M.H.C., with
>5 years’ experience in cardiac MRI), who was masked to the
subject. No gadolinium was given. Summary details of MRI
sequence scan parameters are summarized below.
Cardiac volumes and mass
Left ventricular volumes were assessed using short axis multi-
slice free-breathing real-time steady-state free precision se-
quence [12]. Real-time radial k-t SENSE steady-state free pre-
cision sequence parameters were field of view: approximately
350 mm, matrix: 128×128, voxel size: approximately
2.7×2.7×8 mm, echo time (TE)/repetition time (TR): approx-
imately 1.1/2.2 ms, flip angle: 40°, acceleration factor: 8, and
temporal resolution: approximately 36 ms. Processing of the
left ventricular short axis data was performed as previously
described, enabling measurement of end-diastolic volume,
end-systolic volume, stroke volume, ejection fraction and left
ventricular mass. All ventricular volumes were indexed to
body surface area. The effect of body size on the left ventric-
ular mass was controlled by indexing to height to the power of
2.7 [13]. The right and left atrial areas in diastole were mea-
sured from a four-chamber view and indexed to body surface
area.
Cardiac timing and inflow velocities
Left ventricular outflow tract and mitral inflow velocities were
assessed with a free-breathing high temporal resolution real-
time phase contrast MR sequence [7]. Real-time UNFOLD-
SENSE spiral phase contrast MR sequence parameters were
field of view: approximately 450 mm, matrix: 128×128, voxel
size: approximately 3.5×3.5×7 mm, TE/TR: approximately
1.97/ 7.41 ms, flip angle: 20°, maximum measurable velocity
range: 150 m/s, acceleration factor: 10, and temporal resolu-
tion: approximately 15 ms. The mitral valve orifice and left
ventricular outflow tract were manually segmented from the
resultant inflow and outflow curves to obtain the isovolumic
relaxation time, isovolumic contraction time and ejection time
as previously described [7]. Peak early and atrial diastolic
velocities were also measured from the inflow curves.
Myocardial velocities
Left ventricular myocardial velocities were measured using a
previously validated free-breathing tissue phase mapping
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sequence planned in the mid left ventricular short axis view
[8]. Retrospectively gated golden-angle spiral tissue phase
mapping sequence details were field of view: approximately
400 mm, matrix: 192×192, voxel size: approximately
2.1×2.1×8 mm, TE/TR: approximately 3.51/ 11.7 ms, flip
angle: 15°, respiratory navigation efficiency: 30%, scan time:
approximately 7–8 min, and temporal resolution: approxi-
mately 23 ms. Each acquisition produced a magnitude image
and three phase images (in the x-, y- and z-direction). The
radial velocity was calculated by transforming the x- and y-
direction velocities to an internal polar coordinate system
using the left ventricular center of mass as a reference point.
The longitudinal velocity was taken as velocity in the z-direc-
tion. Global radial and longitudinal left ventricular velocities
were calculated by averaging velocities across the segmented
left ventricular slice for a given direction. The magnitude of
the peak systolic and early diastolic velocities was measured
from the velocity time curves.
Aortic flow
Aortic flow assessment was performed using a breath-held
retrospectively gated phase contrast MR technique just above
the sinotubular junction (Fig. 1) [14]. Retrospectively gated
spiral SENSE phase contrast MR sequence parameters were
field of view: approximately 400 mm, matrix: 256×256, voxel
size: approximately 1.6×1.6×5 mm, TE/TR: approximately
2.1/8.0 ms, flip angle: 25°, acceleration factor: 3, breath-hold
time: 4–8 s, and temporal resolution: approximately 32 ms.
The aorta was segmented to produce a flow curve from which
stroke volume and cardiac output were derived (Fig. 1). The
maximum and minimum cross-sectional areas of the ascend-
ing aorta over the cardiac cycle were also recorded.
Blood pressure measurement
Brachial systolic, diastolic and mean arterial blood pressures
were measured from the right arm in all subjects using anMRI
compatible oscillometric sphygmomanometer (Datex
Ohmeda; General Electric, Boston, USA) during acquisition
of MRI data. This enabled an optimum combination of blood
pressure and flow data for calculating vascular indices. All
blood pressure measurements were acquired with an appropri-
ately sized arm cuff after the subject had been prone in the
scanner for at least 10 min. Pulse pressure was the difference
between systolic and diastolic blood pressure.
Measures of vascular characteristics
Total systemic vascular resistance was calculated by dividing
mean blood pressure by cardiac output [15]. Total arterial
compliance was calculated using a two-element Windkessel
model (Fig. 2) described previously [15]. Briefly, aortic flow
curves were inputted into the model with measured systemic
vascular resistance. The compliance was tuned so that pulse
pressure generated by the model equaled measured pulse pres-
sure (Fig. 2) [15]. Local arterial stiffness was assessed by
calculating ascending aortic compliance = (difference of max-
imum and minimum aortic cross-sectional area)/pulse pres-
sure [16].
Statistics
Statistical analyses were performed using Stata 13 (StataCorp,
College Station, Texas, USA). A P-value<0.05 was consid-
ered statistically significant. Data were examined for normal-
ity using the Shapiro-Wilk normality test and non-normally
distributed data were transformed using a zero-skewness log
transform to ensure normal distribution before analysis.
Descriptive statistics were expressed as mean (±standard de-
viation) or geometric mean (±geometric standard deviation) if
data were log transformed. The chi-square test was used to
determine if there were differences in the use of hypertensive
medications among the three hypertension groups and in gen-
der distribution across all groups. Group differences were
assessed using analysis of variance (ANOVA). Levene’s test
Fig. 1 Phase contrastMR images
acquired at the level of the
ascending aorta of a 15 year old
boy. a Magnitude image, (b)
phase image. The region of
interest (circles) traces the outline
of the cross-sectional aorta area
throughout all phases of the
cardiac cycle to obtain accurate
cardiac output for calculating
systemic vascular resistance and
total arterial compliance
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was used to assess for homogeneity of variances across the
groups and Welch’s correction was applied for nonhomoge-
neous variance. Post hoc pairwise comparison was performed
for significant results on ANOVA, using Duncan’s method to
adjust for potential Type 1 errors. Age- and gender-adjusted
ANOVA tests were also performed for indices with significant
group differences. To determine if group differences in myo-
cardial velocities were due to associated cardiac and vascular
factors, Pearson’s correlations were first performed between
myocardial velocities (with significant group differences) and
possible variables. ANOVA tests for these myocardial veloc-
ities were then repeated after adjustment for any significantly
correlated variables (as well as age and gender).
Results
Study population
The renal cohort consisted of pre-dialysis patients in chronic
kidney disease stages 2–4 (Stage 2: 5 children, Stage 3: 7 chil-
dren, Stage 4: 3 children) with stable renal function. Mean
estimated glomerular filtration rate was 53±25 ml/min/
1.73 m2. The causes of renal impairment were congenital ab-
normalities of the kidney and urinary tract (n=8), renal dysplasia
(n=3), hemolytic uremic syndrome (n=2), glomerulonephritis
(n=1) and tubulointerstitial disease (n=1). All patients were di-
agnosed with hypertension and received hypertensive treatment
(Table 1). Seven (47%) were taking two or more medications.
All renovascular patients had objective evidence of renal
artery stenosis. Of those, 50% (n=6) had bilateral renal artery
stenosis. The majority (n=10) were treated initially with
angioplasty, while the remaining patients received ethanol em-
bolization of a renal artery (n=1), unilateral nephrectomy
(n=1), surgical revascularization (n=1) or medical manage-
ment (n=2). None was awaiting further invasive treatment.
All patients had been deemed by their clinicians to have con-
trolled hypertension with clinically stable blood pressure. The
majority of renovascular children (n=9) continue to receive
hypertension medication (Table 1). Of these, five were taking
two or more drugs. Forty percent (n=6) were no longer on
hypertension medication.
All essential hypertension patients had a diagnosis of idio-
pathic hypertension and had stable treated blood pressure
when last reviewed in the outpatient clinic (Table 2). Five
patients were on two hypertensive medications.
Although there was no difference in age or gender distri-
bution (Table 1), weight was significantly different (P<0.001)
among groups, even after adjusting for age and gender. On
pairwise comparison, the essential hypertension patients were
significantly heavier compared to the renovascular and renal
groups (P≤0.017).
Differences in blood pressure
Blood pressure data are shown in Table 2. Systolic blood pres-
sure was higher in all hypertensive groups compared to the
controls (P<0.001), but there were no differences among the
three hypertension groups (P>0.11). The systolic blood pressure
percentiles were also higher in all the hypertension groups com-
pared to controls (P<0.001). Nineteen patients (four renovascu-
lar, eight renal, seven essential hypertension) had uncontrolled
systolic hypertension (systolic blood pressure >90 percentile).
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Diastolic blood pressure was higher in the hypertension
groups compared to the controls (P≤0.008). In addition, chil-
dren with renal disease had higher diastolic blood pressure
than both the renovascular (P=0.004) and essential hyperten-
sive (P=0.035) groups. A similar pattern was seen in diastolic
blood pressure percentiles, with six patients (no renovascular,
four renal, two essential hypertension) having uncontrolled
diastolic hypertension (diastolic blood pressure >90 percentile)
at the time of the MRI scan.
The mean blood pressure was higher in all hypertension
groups compared to controls (P<0.001). Furthermore, the re-
nal group had a significantly higher mean blood pressure than
Table 2 Vascular phenotype of study population
Healthy controls
n=15
Renal hypertension
n=15
Renovascular hypertension
n=15
Essential hypertension
n=15
P-value
Systolic blood pressure (mmhg) 103±11 125±13b 122±8.4c 128±12e <0.001
Diastolic blood pressure (mmhg) 52±6.6 75±10b 63±12c,d 67±13e,f <0.001
Mean blood pressure (mmhg) 74±5.9 95±8.7b 88±8.6c,d 92±11e <0.001
Pulse pressure (mmhg) 51±12 50±12 59±13 62±9.5e,f 0.016
Systolic blood pressure percentile 25±2.5 76±1.6b 80±1.3c 81±1.3e <0.001g
Diastolic blood pressure percentile 22±14 77±19b 50±31c,d 52±33e,f <0.001g
Cardiac output (l/min/m2)a 3.7±1.2 3.6±1.2 3.6±1.2 3.8±1.2 0.73
Systemic vascular resistance (WU.m2) 20±3.6 27±5.3b 25±5.5c 24±4.3e 0.003
Total arterial compliance (ml/mmHg. m2) 0.59±0.14 0.55±0.11 0.5±0.11c 0.44±0.06e,f 0.002
Ascending aortic compliance (%mmHg−1.102)a 3.2±1.5 2.7±1.5 1.7±1.5c,d 2.2±1.5e <0.001
a Logarithmic transformation was applied
bP-value<0.05 when renal hypertension is compared with controls
cP-value<0.05 when renovascular hypertension is compared with controls
dP-value<0.05 when renovascular hypertension is compared with renal hypertension
eP-value<0.05 when essential hypertension is compared with controls
fP-value<0.05 when essential hypertension is compared with renal hypertension
gANOVAWelch (W) test was used
Table 1 Demographics and baseline characteristics of study population
Healthy controls
n=15
Renal hypertension
n=15
Renovascular hypertension
n=15
Essential hypertension
n=15
P-value
Age (years)a 12±1.3 13±1.3 12±1.3 14±1.3 0.16
Gender (% male)b 53% 60% 73% 73% 0.58
Height (cm) 156±14 154±18 156±18 164±14 0.32
Weight (kg)a 50±1.3 44±1.4 48±1.4c 68±1.4d 0.003
Body mass index (kg/m2) 21±2.3 19±3.6 20±3.6c 26±6.2d 0.010e
Body surface area (m2) 1.5±0.24 1.4±0.3 1.5±0.35c 1.8±0.34d 0.006
Heart rate (beats per minute)a 73±1.2 78±1.3 73±1.2 83±1.2 0.19
Medications (%)b
Angiotensin converting enzyme or
angiotensin 2 receptor inhibitor
67% 20% 53% 0.03
Beta-blocker 40% 33% 13% 0.25
Calcium channel blocker 47% 40% 53% 0.77
a Logarithmic transformation was applied
bA chi-square test was performed. A chi-square test was performed between all four groups for gender. A chi-square test was performed between the
three hypertensive groups for medications
cP value<0.05 when renovascular hypertension is compared to hypertension
dP<0.05 when essential hypertension is compared with controls; P<0.05 when hypertension is compared with renal hypertension
e ANOVAWelch (W) test was used
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the renovascular group (P=0.027). Conversely, pulse pressure
was only elevated in the essential hypertension children com-
pared to the controls (P=0.019). The pulse pressure was also
significantly higher in the essential hypertension patients com-
pared to the renal patients (P=0.012). These differences
remained broadly present after controlling for age and gender.
Vascular properties
Vascular measures are shown in Table 2. Systemic vascular
resistance was higher in all hypertension groups compared to
the controls (P≤0.028) and there were no significant differ-
ences between the hypertension groups (P>0.15). However,
after correcting for age and gender, the systemic vascular re-
sistance in the essential hypertension group was no longer
significantly different from the controls (P=0.13).
Total arterial compliance was significantly lower in the
essential hypertension and renovascular groups compared to
the controls (P≤0.026) and in the essential hypertension group
compared to the renal children (P=0.01). Local ascending aor-
tic compliance was also lower in the essential hypertension
and renovascular children compared to the controls
(P≤0.018). Furthermore, the renovascular children had signif-
icantly lower ascending aortic compliance compared to the
renal patients (P=0.005). Differences in total and local com-
pliance remained after correcting for age and gender. The car-
diac output was similar in all groups (Table 2).
Cardiac structure and global function
Left ventricular volumes and function are shown in Table 3.
There were no significant differences in the left ventricular
volumes or function among the groups, including after age
and gender correction. There was also no difference in height
indexed left ventricular mass among the groups.
Mitral valve inflow and cardiac timing measures are shown
in Table 3. There were no significant group differences in
early or late mitral inflow velocities, early to late mitral veloc-
ities ratio, or isovolumic times, including after correcting for
age and gender.
Myocardial velocities
Myocardial velocities are shown in Table 4. There were no
differences between the radial peak systolic velocity in the
hypertension groups and the controls (P>0.12). However, re-
nal and renovascular children did have lower radial peak sys-
tolic velocities compared to the essential hypertension chil-
dren (P=0.009 and P=0.047, respectively). After adjustments
for age and gender, only renal children had lower radial peak
systolic velocities than both the controls and the essential hy-
pertension children (P=0.027 and P=0.029, respectively).
Radial peak systolic velocity was negatively correlated with
systemic vascular resistance (r=−0.3, P=0.022) and positively
correlated with left ventricular mass (r=0.26,P=0.049). Radial
peak systolic velocity did not correlate with other hemody-
namic metrics (P>0.15). Group differences in radial peak sys-
tolic velocities were abolished after adjusting for systemic
vascular resistance (P=0.41), but they remained after adjust-
ment for left ventricular mass (P=0.043). There were no group
differences in longitudinal peak systolic velocity.
The radial early diastolic velocity was significantly reduced
in the renal group compared to both the controls (P=0.009)
and the renovascular children (P=0.009). These differences
remained after correcting for the influence of age and gender.
Radial early diastolic velocity only correlated with diastolic
blood pressure (r=0.43, P<0.001), mean blood pressure
(r=0.31, P=0.017), systemic vascular resistance (r=0.47,
P<0.001) and radial peak systolic (r=0.53, P<0.001). Group
differences remained after adjusting for systemic vascular re-
sistance (P=0.045) or radial peak systolic (P=0.022), but were
abolished after adjusting for diastolic (P=0.25) or mean blood
pressure (P=0.11).
The longitudinal early diastolic velocity was significantly
increased in the essential hypertension group compared to the
controls (P=0.009), the renovascular (P=0.006) and the renal
children (P=0.009). These differences remained after correcting
for the influence of age and gender. The longitudinal early
diastolic velocity was only correlated with the left ventricular
mass (r=0.30, P=0.02). After adjusting for the left ventricular
mass, there was only a trend for group differences (P=0.055).
Discussion
This study investigated the cardiovascular phenotype in dif-
ferent forms of treated hypertension in childrenwithMRI. Our
findings were:
& Systemic vascular resistance was elevated in children with
renal and renovascular disease, but was normal in essential
hypertension after adjusting for age and gender.
& Arterial stiffness (i.e. lower total arterial compliance and
ascending aortic compliance) was higher in essential hyper-
tension and renovascular, but was normal in renal disease.
& Children with renal disease had reduced radial systolic and
diastolic function (lower peak systolic and early diastolic
myocardial velocities, respectively) compared to the con-
trols and the other hypertension groups.
Vascular phenotype
It is increasingly recognised that differences in the pattern of
hypertension is associated with differential mortality risk [17].
Systolic and diastolic hypertension in young adults, which is
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associated with an elevated systemic vascular resistance, have
been shown to be associated with the highest risk when com-
pared to other patterns of hypertension such as isolated sys-
tolic hypertension [17]. Thus, the pattern of hypertension is
closely related to the vascular phenotype and may provide
valuable prognostic information [18].
In this study, the blood pressure phenotype in the three
hypertension groups was slightly different, despite having
similar systolic blood pressure. Specifically, the renal patients
had higher diastolic blood pressure and mean blood pressure,
while the essential hypertension group had greater pulse pres-
sure. These findings are in keeping with previous large studies
of blood pressure in these populations [5, 19] and suggest
differing vascular abnormalities. However, it is not possible
to definitively characterize vascular phenotype using this in-
formation because of the important role of cardiac output in
determining blood pressure. Therefore, we combined blood
pressure measurements with cardiac MRI to assess cardiac
output and calculate systemic vascular resistance and total
arterial compliance. This allowed full characterization of vas-
cular phenotype and ruled out the possibility that blood pres-
sure differences were simply due to differences in cardiac
output.
We demonstrated that hypertensive renal disease was asso-
ciated with increased systemic vascular resistance, whilst es-
sential hypertension was characterized by decreased total
Table 3 Assessment of myocardial structure and left ventricular systolic and diastolic function
Healthy controls
n=15
Renal hypertension
n=15
Renovascular hypertension
n=15
Essential hypertension
n=15
P-value
End-diastolic volume (ml/m2) 74±9.4 69±12 69±9.3 70±9.8 0.45
End-systolic volume (ml/m2) 23±4.2 22±5.9 19±7.8 22±5.3 0.22
Stroke volume (ml/m2) 51±6.4 47±9.2 50±7.1 47±5.4 0.33
Indexed left ventricular mass (g/m2.7) 23±2.9 23±6.3 25±5.4 27±6.7 0.14
Right atrial area (cm2/m2) 12±1.6 11±1.9 11±2.1 11±1.4 0.06
Left atrial area (cm2/m2)a 12±1.3 12±1.2 12±1.1 10±1.1b 0.04
Ejection fraction (%) 69±3.4 68±6.2 73±9.1 68±3.8 0.32c
Isovolumic relaxation time (ms) 64±11 70±12 67±11 69±13 0.51
Isovolumic contraction time (ms) 47±15 41±14 54±27 49±22 0.41c
Early diastolic (E) mitral flow (ml) 47±9.6 52±9.8 57±11 48±9.8 0.05
Late diastolic (A) mitral flow (ml) 19±4.2 21±6.6 25±6.6 23±5.7 0.11
E/A ratioa 2.5±1.2 2.5±1.6 2.3±1.4 2.2±1.3 0.60
Ejection time (ms) 278±19 277±13 276±22 266±15 0.27
a Logarithmic transformation was applied
bP<0.05when essential hypertension is comparedwith controls,P<0.05when essential hypertension is comparedwith renal hypertension, P<0.05when
renovascular hypertension is compared to essential hypertension
c ANOVAWelch (W) test was used
Table 4 Assessment of myocardial velocities
Healthy
controls
n=15
Renal
hypertension
n=15
Renovascular
hypertension
n=15
Essential
hypertension
n=15
P-
value
Radial peak systolic myocardial velocity (cm/s) 2.7±0.41 2.5±0.42 2.6±0.27 2.9±0.3d 0.035
Radial early diastolic velocity (cm/s) 4±0.85 3.3±0.65b 4±0.7c 3.8±0.39 0.018
Longitudinal peak systolic myocardial velocity
(cm/s)a
4±1.3 3.3±1.4 3.3±1.5 3.7±1.2 0.31
Long early diastolic velocity (cm/s) 7.5±1.8 7.6±2.2 7.3±1.9 9.5±1.7d,e 0.01
a Logarithmic transformation was applied
bP<0.05 when renal hypertension is compared with controls
cP<0.05 when renovascular hypertension is compared with renal hypertension
dP<0.05 when renovascular hypertension is compared to essential hypertension, P<0.05 when essential hypertension is compared with renal
hypertension
eP-value<0.05 when essential hypertension compared with controls
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arterial compliance and ascending aortic compliance.
Children with renovascular hypertension fell somewhere in
between these two groups. These findings are in keeping with
the blood pressure phenotypes of elevated pulse pressure in
the essential hypertension patients and elevated mean blood
pressure in the renal disease patients. However, it should be
noted that this is a treated population and untreated children
may have different or more marked vascular abnormalities.
Consequently, extrapolating these findings may be premature,
and further studies are required. Nevertheless, our findings
suggest that treated children cannot be considered to have
normal vascular phenotype.
Raised systemic vascular resistance is known to occur in
renal parenchymal disease [20] and possible causes include
persistent abnormal renin-angiotensin stimulation [21], sym-
pathetic overdrive [22] and reduced endothelial nitric oxide
bioavailability [23]. Conversely, reduced total arterial compli-
ance and increased pulse pressure are recognised to be central
to the development of essential hypertension [24–26]. Our
data further suggest that even after treatment, the essential
hypertension children continue to have increased vessel
stiffness.
Renal artery stenosis results in renal ischaemia, which in
turn leads to wide-ranging maladaptive neurohumoral and
vascular responses. Vasoconstriction is primarily mediated
through renin-angiotensin-aldosterone axis activation and in-
creased sympathetic activity in renovascular hypertension
[27, 28]. Thus, renovascular children would be expected to
have significantly elevated systemic vascular resistance before
invasive treatment [27, 28].
Our results indicate that this does not completely normalize
after therapy. Furthermore, the increased arterial stiffness in
renovascular cases suggests that any abnormal vascular re-
modelling that may be the result of high pre-treatment blood
pressure appears to persist despite successful therapy.
The fact that these treated patients continue to have raised
blood pressure is important as even mildly elevated blood
pressure confers additional cardiovascular risk, particularly
in those burdened from a young age [17]. Thus, further treat-
ment escalation may be appropriate and better understanding
of the underlying pathophysiology might help determine suc-
cess. For instance, children with renal disease may benefit
from more aggressive vasodilation with more use of calcium
channel blockers. Conversely, essential hypertension patients
may be better treated with newer therapies such as neprilysin
inhibitors (e.g., Sacubitril/Valsartan) that target aortic stiffness
[18].
Cardiac phenotype
One of the major benefits of using MRI to assess these chil-
dren is the ability to comprehensively evaluate the myocardial
response to elevated blood pressure. In this study,
conventional metrics of left ventricular systolic and diastolic
function were normal. Furthermore, the left ventricular mass
was not increased in the hypertension groups. The lack of
significant changes in the left ventricular structure and global
function is probably related to the fact that this was a treated
population. However, we did find abnormal myocardial ve-
locities with both radial peak systolic and early diastolic ve-
locities being different amongst the groups. We also showed
that radial peak systolic and early diastolic velocities correlat-
ed with measures of afterload, particularly systemic vascular
resistance (peak systolic and early diastolic velocities) and
diastolic blood pressure (early diastolic velocities). This is in
keeping with the well-recognized association between
afterload and both systolic and diastolic function [29].
Interestingly, there were no group differences in radial peak
systolic or early diastolic velocities in models adjusted for
systemic vascular resistance (for peak systolic velocity) or
diastolic blood pressure (for early diastolic velocity). This
suggests that differences in myocardial velocities in the differ-
ent groups of pediatric hypertension are at least partly ex-
plained by differences in vascular phenotype. However, our
findings do not preclude direct myocardial disease in some of
these patients (particularly the renal children) due to the small
patient population.
There is also evidence from our study that radial early
diastolic velocity correlates with radial peak systolic velocity.
This is in keeping with the known association between systol-
ic and diastolic function [30], but did not explain group dif-
ferences in radial early diastolic velocities. A surprising find-
ing of this study was that patients with essential hypertension
appeared to have higher longitudinal early diastolic velocities.
We think this is due to the higher bulk motion of the heart in
essential hypertension patients, rather than better myocardial
relaxation. Although it is possible to correct for radial bulk
motion using short axis tissue phase mapping, it is not possi-
ble to correct for longitudinal bulk motion. This is a limitation
of this technique and in the future, four-chamber or long axis
approaches should be considered.
Limitations
The main limitation of this study is the small number of pa-
tients in each group. The main reason for the small numbers
was the difficulty in recruiting renal artery stenosis patients.
Renal artery stenosis is a relatively rare condition and may be
associated with other comorbidities. As other conditions such
as significant midaortic syndrome may have potential con-
founding effects, it was important that only a “pure” popula-
tion of renal artery stenosis was included in the study. Hence,
it was not possible to recruit a larger number of renal artery
stenosis children from a single-centre study. However, in spite
of that, we were able to demonstrate significant differences in
cardiovascular structure and function among the groups using
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MRI. Nevertheless, larger multicentre studies are required
to properly confirm our results. The relatively small study
numbers also precluded the inclusion of additional poten-
tial confounding factors into the ANOVA models such as
differences in hypertensive treatment and the length of
treatment among the groups. Variation in current medica-
tion therapy may contribute to differences in vascular phe-
notype among the groups. Future studies will need to con-
sider multicentre recruitment to increase the power of the
study population to adjust for the potential effects of dif-
ferent hypertensive treatment.
Another important limitation was that the majority of pa-
tients were being actively treated with anti-hypertensive med-
ication. This was because of difficulties in recruiting patients
before they began therapy. In particular, most patients were
referred to our center having already been diagnosed with
hypertension and started on therapy. This also made it difficult
to ascertain the length of diagnosis and therapy. Thus, we
cannot make firm conclusions about the differences in cardiac
and vascular phenotype in treatment-naïve patients or the re-
sponse to treatment in the different groups. In particular, we
are not powered to investigate the effect of length of treatment
on vascular or cardiac phenotype. Nonetheless, we were able
to demonstrate persistent vascular changes associated with
renal disease and hypertension despite optimal clinical treat-
ment in this population. Future studies should consider a pro-
spective evaluation of the effects of anti-hypertensive therapy
in treatment-naïve children, including investigation of the time
course of any improvements.
A final limitation is that the supine resting position may
also be associated with elevated systemic vascular resistance
[31]. However, as the method for systemic vascular resistance
assessment was applied identically across the entire study co-
hort, the intergroup differences demonstrated in the study are
likely to be significant.
Conclusion
We have shown that there are differences in vascular and
cardiac phenotype among the different types of treated hyper-
tension in childhood. Future studies in treatment naïve chil-
dren are needed to better understand if these different pheno-
types have any prognostic implications or could be used to
optimise blood pressure control.
Acknowledgements We would like to express our gratitude to our re-
search radiographers and all the doctors and nurses in the renal depart-
ment in Great Ormond Street Hospital. This work was supported by Kids
Kidney Research Charity, UK, and the National Institute for Health
Research Biomedical Research Centre at Great Ormond Street Hospital
for the Children National Health Service Foundation Trust and University
College London. This study was funded by Kids Kidney Research,
United Kingdom.
Compliance with ethical standards
Conflicts of interest None
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Hansen ML, Gunn PW, Kaelber DC (2007) Underdiagnosis of
hypertension in children and adolescents. JAMA 298:874–879
2. Sharma AK, Metzger DL, Rodd CJ (2018) Prevalence and severity
of high blood pressure among children based on the 2017 American
Academy of Pediatrics guidelines. JAMA Pediatr 172:557–565
3. Gupta-Malhotra M, Banker A, Shete S et al (2015) Essential hyper-
tension vs. secondary hypertension among children. Am J
Hypertens 28:73–80
4. Sadowski RH, Falkner B (1996) Hypertension in pediatric patients.
Am J Kidney Dis 27:305–315
5. Cheang MH, Barber NJ, Khushnood A et al (2018) A comprehen-
sive characterization of myocardial and vascular phenotype in pe-
diatric chronic kidney disease using cardiovascular magnetic reso-
nance imaging. J Cardiovasc Magn Reson 20:24
6. Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indica-
tions for cardiovascular magnetic resonance (CMR): consensus
panel report. J Cardiovasc Magn Reson 6:727–765
7. Kowalik GT, Knight DS, Steeden JA et al (2015) Assessment of
cardiac time intervals using high temporal resolution real-time spi-
ral phase contrast with UNFOLDed-SENSE. Magn ResonMed 73:
749–756
8. Steeden JA, Knight DS, Bali S et al (2014) Self-navigated tissue
phase mapping using a golden-angle spiral acquisition-proof of
concept in patients with pulmonary hypertension. Magn Reson
Med 71:145–155
9. Tullus K, Brennan E, Hamilton G et al (2008) Renovascular hyper-
tension in children. Lancet 371:1453–1463
10. McCrindle BW (2010) Assessment and management of hyper-
tension in children and adolescents. Nat Rev Cardiol 7:155–
163
11. Odille F, Steeden JA,Muthurangu V, Atkinson D (2011) Automatic
segmentation propagation of the aorta in real-time phase contrast
MRI using nonrigid registration. J Magn Reson Imaging 33:232–
238
12. Muthurangu V, Lurz P, Critchely JD et al (2008) Real-time assess-
ment of right and left ventricular volumes and function in patients
with congenital heart disease by using high spatiotemporal resolu-
tion radial k-t SENSE. Radiology 248:782–791
13. de Simone G, Devereux RB, Daniels SR et al (1995) Effect of
growth on variability of left ventricular mass: assessment of allo-
metric signals in adults and children and their capacity to predict
cardiovascular risk. J Am Coll Cardiol 25:1056–1062
14. Steeden JA, Atkinson D, Hansen MS et al (2011) Rapid flow as-
sessment of congenital heart disease with high-spatiotemporal-
resolution gated spiral phase-contrast MR imaging. Radiology
260:79–87
15. Steeden JA, Atkinson D, Taylor AM, Muthurangu V (2010)
Assessing vascular response to exercise using a combination of
Pediatr Radiol (2019) 49:727–736 735
real-time spiral phase contrast MR and noninvasive blood pressure
measurements. J Magn Reson Imaging 31:997–1003
16. Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus
document on arterial stiffness: methodological issues and clinical
applications. Eur Heart J 27:2588–2605
17. Yano Y, Stamler J, Garside DB et al (2015) Isolated systolic hyper-
tension in young and middle-aged adults and 31-year risk for car-
diovascular mortality: the Chicago heart association detection pro-
ject in industry study. J Am Coll Cardiol 65:327–335
18. Smulyan H, Mookherjee S, Safar ME (2016) The two faces of
hypertension: role of aortic stiffness. J Am Soc Hypertens 10:
175–183
19. Domanski MJ, Davis BR, Pfeffer MA et al (1999) Isolated systolic
hypertension: prognostic information provided by pulse pressure.
Hypertension 34:375–380
20. Mitsnefes MM, Knilans T, MaysWet al (2005) Blood pressure and
total peripheral resistance in children with chronic kidney disease.
Pediatr Nephrol 20:803–806
21. Van Biesen W, Verbeke F, Devolder I, Vanholder R (2008) The
relation between salt, volume, and hypertension: clinical evidence
for forgotten but still valid basic physiology. Perit Dial Int 28:596–
600
22. Grassi G, Quarti-Trevano F, Seravalle G et al (2011) Early sympa-
thetic activation in the initial clinical stages of chronic renal failure.
Hypertension 57:846–851
23. Vaziri ND (2001) Effect of chronic renal failure on nitric oxide
metabolism. Am J Kidney Dis 38:S74–S79
24. Li S, Chen W, Srinivasan SR, Berenson GS (2004) Childhood
blood pressure as a predictor of arterial stiffness in young adults:
the Bogalusa heart study. Hypertension 43:541–546
25. Urbina EM, Khoury PR, McCoy C et al (2011) Cardiac and vascu-
lar consequences of pre-hypertension in youth. J Clin Hypertens
(Greenwich) 13:332–342
26. Donald AE, Charakida M, Falaschetti E et al (2010) Determinants
of vascular phenotype in a large childhood population: the Avon
Longitudinal Study of Parents and Children (ALSPAC). Eur Heart J
31:1502–1510
27. Parikh SA, Shishehbor MH, Gray BH et al (2014) SCAI expert
consensus statement for renal artery stenting appropriate use.
Catheter Cardiovasc Interv 84:1163–1171
28. Martinez-Maldonado M (1991) Pathophysiology of renovascular
hypertension. Hypertension 17:707–719
29. Borlaug BA, Melenovsky V, Redfield MM et al (2007) Impact of
arterial load and loading sequence on left ventricular tissue veloci-
ties in humans. J Am Coll Cardiol 50:1570–1577
30. Simpson JM, Rawlins D, Mathur S et al (2013) Systolic and dia-
stolic ventricular function assessed by tissue Doppler imaging in
children with chronic kidney disease. Echocardiography 30:331–
337
31. Aoki K, Sato K (1986) Decrease in blood pressure and increase
in total peripheral vascular resistance in supine resting subjects
with normotension or essential hypertension. Jpn Heart J 27:
467–474
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
736 Pediatr Radiol (2019) 49:727–736
